|
RINT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28369999999423E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.193810E-02 |
| Normal-vs-Stage2 |
6.728200E-02 |
| Normal-vs-Stage3 |
1.949030E-01 |
| Normal-vs-Stage4 |
1.627200E-01 |
| Stage1-vs-Stage2 |
4.568400E-01 |
| Stage1-vs-Stage3 |
9.806400E-01 |
| Stage1-vs-Stage4 |
3.747000E-01 |
| Stage2-vs-Stage3 |
5.291800E-01 |
| Stage2-vs-Stage4 |
7.860600E-01 |
| Stage3-vs-Stage4 |
4.383600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.422920E-04 |
| Normal-vs-AfricanAmerican |
6.334500E-02 |
| Normal-vs-Asian |
4.3475000000015E-07 |
| Caucasian-vs-AfricanAmerican |
7.374200E-01 |
| Caucasian-vs-Asian |
1.611940E-02 |
| AfricanAmerican-vs-Asian |
1.477580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.951100E-04 |
| Normal-vs-Female |
9.784200E-04 |
| Male-vs-Female |
4.491000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.693500E-02 |
| Normal-vs-Extreme_Weight |
1.063910E-02 |
| Normal-vs-Obese |
2.446200E-02 |
| Normal-vs-Extreme_Obese |
4.524000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.538600E-01 |
| Normal_Weight-vs-Obese |
6.228600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.596400E-01 |
| Extreme_Weight-vs-Obese |
9.382200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.882800E-01 |
| Obese-vs-Extreme_Obese |
7.124800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.302000E-03 |
| Normal-vs-Age(41-60Yrs) |
8.12159999999951E-05 |
| Normal-vs-Age(61-80Yrs) |
2.239600E-02 |
| Normal-vs-Age(81-100Yrs) |
5.024400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.036610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.244440E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.069200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.172200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.371800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.879600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.98470000118456E-08 |
| Normal-VS-Type2 PRCC |
8.734400E-01 |
| Normal-VS-KIRP CIMP |
1.601950E-01 |
| Normal-VS-Unclassified PRCC |
1.053420E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.215260E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.102600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.678200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.306840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.285590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.841800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.844970E-01 |
| Normal-vs-N1 |
8.022400E-02 |
| Normal-vs-N2 |
4.615400E-01 |
| N0-vs-N1 |
4.766400E-01 |
| N0-vs-N2 |
4.813000E-01 |
| N1-vs-N2 |
3.016200E-01 |
|
|
